These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9769651)

  • 21. Occurrence of tick-borne encephalitis and other arboviruses in Hungary.
    Molnár E
    Geogr Med; 1982; 12():78-120. PubMed ID: 6129178
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaccine failures after active immunisation against tick-borne encephalitis.
    Andersson CR; Vene S; Insulander M; Lindquist L; Lundkvist A; Günther G
    Vaccine; 2010 Apr; 28(16):2827-31. PubMed ID: 20167301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tick-borne encephalitis and Lyme disease in Hungary: the epidemiological situation between 1998 and 2008.
    Zöldi V; Juhász A; Nagy C; Papp Z; Egyed L
    Vector Borne Zoonotic Dis; 2013 Apr; 13(4):256-65. PubMed ID: 23428090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.
    Kleiter I; Jilg W; Bogdahn U; Steinbrecher A
    Infection; 2007 Feb; 35(1):26-9. PubMed ID: 17297586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.
    Bröker M; Kollaritsch H
    Vaccine; 2008 Feb; 26(7):863-8. PubMed ID: 18206274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs.
    Stiasny K; Holzmann H; Heinz FX
    Vaccine; 2009 Nov; 27(50):7021-6. PubMed ID: 19789092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tick-borne encephalitis in the North part of the canton de Vaud].
    Schlaefli R; Randin D; Wyss P; de Vallière S; Meylan P; Cometta A
    Rev Med Suisse; 2007 Nov; 3(133):2609-13. PubMed ID: 18078192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines and vaccination against tick-borne encephalitis.
    Kollaritsch H; Paulke-Korinek M; Holzmann H; Hombach J; Bjorvatn B; Barrett A
    Expert Rev Vaccines; 2012 Sep; 11(9):1103-19. PubMed ID: 23151167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tick borne encephalitis (TBE)-vaccination coverage and analysis of variables associated with vaccination, Sweden.
    Askling HH; Insulander M; Hergens MP; Leval A
    Vaccine; 2015 Sep; 33(38):4962-8. PubMed ID: 26207593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tick-borne encephalitis (TBE) trends in epidemiology and current and future management.
    Petri E; Gniel D; Zent O
    Travel Med Infect Dis; 2010 Jul; 8(4):233-45. PubMed ID: 20970726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines.
    Hainz U; Jenewein B; Asch E; Pfeiffer KP; Berger P; Grubeck-Loebenstein B
    Vaccine; 2005 May; 23(25):3232-5. PubMed ID: 15837226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiology of tick-borne encephalitis in Leningrad].
    Antykova LP
    Tr Inst Im Pastera; 1989; 65():21-5. PubMed ID: 2483468
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation.
    Rendi-Wagner P; Kundi M; Zent O; Banzhoff A; Jaehnig P; Stemberger R; Dvorak G; Grumbeck E; Laaber B; Kollaritsch H
    Vaccine; 2004 Dec; 23(4):427-34. PubMed ID: 15530690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
    Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
    J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Active immunization against tick-born encephalitis (TBE) among border guards (1993-2002)].
    Knap J; Ryba S
    Przegl Epidemiol; 2002; 56 Suppl 1():110-6. PubMed ID: 12194224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tick-borne encephalitis as a notifiable disease--Status quo and the way forward. Report of the 17th annual meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE).
    Kunze U;
    Ticks Tick Borne Dis; 2015 Jul; 6(5):545-8. PubMed ID: 26025269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the serological response after vaccination against tick-borne encephalitis in Sweden.
    Vene S; Haglund M; Lundkvist A; Lindquist L; Forsgren M
    Vaccine; 2007 Jan; 25(2):366-72. PubMed ID: 16959384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area--impact on current recommendations for immunization of high-risk groups.
    Plísek S; Honegr K; Beran J
    Vaccine; 2008 Jan; 26(3):301-4. PubMed ID: 18082914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of antibodies after vaccination against tick-borne encephalitis.
    Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
    Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.